Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
1
x
$
30.00
Patient Response Trajectories in Major Depressive Disorder
1
x
$
30.00
Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
1
x
$
30.00
The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic
1
x
$
30.00
The Genetics of Multiple Myeloma
1
x
$
0.00
Psychopharmacology Bulletin VOL 36 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
1
x
$
30.00
View Cart
Checkout
Home
james-eudicone
“Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Page load link
Go to Top